|
octreoscan.kcsolid.cz - stránky věnované
přípravku
OctreoScan
ALEXANDER
H.R., FRAKER D.L, NORTON J.A., BARTLETT D.L., TIO L., BENJAMIN S.B.,
DOPPMAN J.L., GOEBEL S.U., SERRANO J., GIBRIL F. &
R.T.JENSEN, 1998: Prospective
Study of Somatostatin Receptor Scintigraphy and its Effect on
Operative Outcome in Patients With Zollinger-Ellison Syndrome: Annals
of Surgery, Vol. 228(2),
228-238.
GIBRIL
F., DOPPMAN J.L, REYNOLDS J.C., CHEN C., SUTLIFF V.E., YU F., SERRANO
J., VENZON D.J &
R.T.JENSEN, 1998: Bone
Metastasis in Patients with Gastrinomas: A Prospective Study of Bone
Scanning, Somatostatine Receptor scanning, and Magnetic Resonance
image in Their Detection, Frequency, Location nad Effect of Their
Detection on Management. Journal of Clinical Oncology, Vol. 16 (3), pp. 1040-1053.
GIBRIL
F., REYNOLDS J.C., DOPPMAN J.L, CHEN C., VENZON D.J, TERMANINI B.,
WEBER C., STEWART C.A &
R.T.JENSEN, 1996: Somatostatin
Receptor Scintigraphy: Its Sensitivity Compared with That of other
Imaging Methods in Detecting Primary and Metastatic Gastrinomas. A
Prospective Study. Annals of
Internal Medicine, Vol. 125
(1), pp. 26-34.
GIBRIL
F., REYNOLDS J.C., LUBENSKY I.A., ROY P.K., PEGHINI P.L., DOPMANN J.L.
&
R.T.JENSEN, 2000: Ability
of Somatostatin Receptor Scintigraphy to Identify Patients with
Gastric Carcinoids: A Prospective Study. Journal
of Nuclear Medicine, Vol. 41
(10), pp. 1646-1656.
GIBRIL
F., REYNOLDS J.C., CHEN C., YU F., GOEBEL S.U., SERRANO J., DOPMANN J.L.
&
R.T.JENSEN, 1998: Specifity
of Somatostatin Receptor Scintigraphy: A Prospective study and Effects
of False-Positive Localisations on Management in patients with
Gastrinomas. Journal of Nuclear
Medicine, Vol. 40 (4),
pp. 539-553.
KRENNING
E.P., KWEKKEBOOM D.J., BAKKER W.H., BREEMAN W.A.P., KOOIJ P.P.M, OEI H.Y.,
van HAGEN M., POSTEMA P.T.A., de JONG M., REUBI J.C., VISSER T.J,
REIJS T.J., HOFLAND L.J., KOPER J.W. &
S.W.J. LAMBERT, 1993:
Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]-
and [123I-Tyr3]-octreotide:
the Rotterdam experience with more than 1000 patients. European
Journal of Nuclear Medicine, Vol 20., pp. 716-731.
KRENNING
E.P., KWEKKEBOOM D.J., OEI H.Y., de JONG M., DOP F.J., REUBI J.C. &
S.W.J. LAMBERT: Somatostatin
receptor Scintigraphy in Gastroenteropancreatic Tumors: An Overwiev of
European Results. Annals New-York Academy of Sciences, pp. 416-424.
KRENNING
E.P., de JONG M., KOOIJ P.P.M, BREEMAN W.A.P., BAKKER W.H., de HERDER
W.W., van EIJCK C.H.J., KWEKKEBOOM D.J., JAMAR J, PAUWELS S. &
R. VALKEMA, 1999: Radiolabelled somastostatin analogue(s) for
peptide receptor scintigraphy and radionuclide therapy. Annals of Oncology, Vol. 10,
pp. 23-29.
KWEKKEBOOM
D.J., HOFF A.M., LAMBERTS S.W.J., OEI H.Y &
E.P. KRENNING, 1992: Somatostatin
Analogue Scintigraphy: A Simple and Sensitive Method for the In Vivo
Visualisation of Merkell Cell Tumors and Their Metastases. Arch.
Dermatol., Vol. 128, pp.818-821.
LUGTENBURG
P.J., KRENNING E.P., VALKEMA R., OEI H.Y, LAMBERTS S.W.J. EIJKMANS M.J.C.,
van PUTTEN W.L.J. &
B. LÖWENBERG, 2001: Somatostatin
Receptor Scintigraphy Useful in Stage I-II Hodgkins disease: more
extended disease identified. British
Journal of Haematology, Vol. 112,
pp. 936-944.
LUGTENBURG
P.J., LÖWENBERG B.,
VALKEMA R., OEI H.Y, LAMBERTS S.W.J., EIJKMANS M.J.C., van PUTTEN W.L.J.
&
E.P. KRENNING E.P., 2001: Somatostatin
Receptor Scintigraphy in the initial Staging of Low-Grade Non-Hodgkins
Lymphomas. Journal of Nuclear Medicine, Vol. 42 (2), pp. 222-229.
PROYE
C., MALVAUX P., PATTOU F., FILOCHE B., GODCHAUC J.-M., V. MAUNOURY,
PALAZZO L., HUGLO D., LEFEBVRE J. &
J.-C. PARIS, 1998:
Noninvasive Imaging of Insulinomas and Gastrinomas with Endoscopic
Ultrasonography and Somatostatin Receptor Scintigraphy. Proccedings of
19-th Meeting of American Association of Endocrine Surgeons.
JAMAR
F., FIASSE R., LENERS N. &
S. PAUWELS, 1994: Somatostatin
Receptor Imaging with Indium-111-Pentetreotide in
Gastroenteropancreatic neuroendocrine Tumors: Safety, Efficacy and
Impact on Patient Management. Journal
of Nuclear Medicine, Vol. 36
(4), pp. 542-549.
GARIN
E., DEVILLIERS A., Le CLOIREC L., BERNARD A.M, LESCOUARCH J., HERRY J.Y.,
REUBI J.C. &
P. BOURGUET, 1998: Use
of indium-111 pentetreotide somatostatin receptor scintigraphy to
detect recurrent thyroid carcinoma in patients without detectable
iodine uptake. European Journal of Nuclear Medicine, Vol. 25(7), pp. 687-694.
SCHILLACI
O., CORLETO V.D., ANNIBALE B., SCOPINARO F. &
G. DELLE FAVE, 1999: Single
photon emission computed tomography procedure improves accuracy of
somatostatin receptor scintigraphy in gastro-entero pancreatic tumours.
Italian Journal of Gastroenterol.
and Hepatol., Vol. 31 (2),
pp- 186-189.
SCHMIDT
M., SCHEIDHAUER K., LUYKEN C., VOTH E., HILDEBRANDT G., KLUG N. &
H. SCHICHA, 1998:
Somatostatin Receptor imaging in Intracranial Tumours. European
Journal of Nuclear Medicine, Vol.
25 (7), pp 675-686.
SLOOTER
G.D., MEARADJI A., BREEMAN W.A.P., MARQUET R.LO., de JONG M., KRENNING
E.P. &
C.H.J. van EIJCK, 2001:
Somatostatin Receptor Imaging, therapy and new strategies in patients
with neuroendocrine tumours. British
Journal of Surgery,
Vol. 88, pp. 31-40.
TERMANINI
B., GIBRIL F., DOPPMAN J.L, REYNOLDS J.C., STEWART C.A., SUTLIFF
V.E., VENZON D.J &
R.T. JENSEN, 1997: Distuingushing
Small Hepatic Hemangiomas from Vascular Liver Metastases in Gastrinoma:
Use of a Somatostatin-Receptor Scintigraphic Agent. Radiology,
Vol. 202, pp. 151-158.
TERMANINI
B., GIBRIL F., REYNOLDS J.C., DOPPMAN J.L, CHEN C.C., STEWART C.A., SUTLIFF
V.E. &
R.T. JENSEN, 1997: Value of Somatostatin Receptor Scintigraphy: A
Prospective Study in Gastrinoma of its Effect on Clinical Management. Gastroenterology,
Vol. 112: 335-347.
Pokud byste měli
o některou z těchto prací zájem, kontaktujte
nás e-mailem nebo telefonicky.
<<
ZPĚT
^
nahoru
|
|
